Back to Search
Start Over
Mineralocorticoid receptor activation and mineralocorticoid receptor antagonist treatment in cardiac and renal diseases.
- Source :
-
Hypertension (Dallas, Tex. : 1979) [Hypertension] 2015 Feb; Vol. 65 (2), pp. 257-63. Date of Electronic Publication: 2014 Nov 03. - Publication Year :
- 2015
- Subjects :
- 11-beta-Hydroxysteroid Dehydrogenases physiology
Aldosterone physiology
Animals
Blood Pressure physiology
Clinical Trials as Topic
Drug Evaluation, Preclinical
Fibrosis
Heart physiology
Heart Diseases drug therapy
Humans
Hydrocortisone physiology
Hyperkalemia chemically induced
Hypertension drug therapy
Hypertension physiopathology
Inflammation
Kidney physiology
Kidney Diseases drug therapy
Mineralocorticoid Receptor Antagonists adverse effects
Mineralocorticoid Receptor Antagonists pharmacology
Models, Biological
Multicenter Studies as Topic
Oxidative Stress
Potassium metabolism
Receptors, Mineralocorticoid drug effects
Signal Transduction drug effects
Signal Transduction physiology
Sodium metabolism
Heart Diseases physiopathology
Kidney Diseases physiopathology
Mineralocorticoid Receptor Antagonists therapeutic use
Receptors, Mineralocorticoid physiology
Subjects
Details
- Language :
- English
- ISSN :
- 1524-4563
- Volume :
- 65
- Issue :
- 2
- Database :
- MEDLINE
- Journal :
- Hypertension (Dallas, Tex. : 1979)
- Publication Type :
- Academic Journal
- Accession number :
- 25368026
- Full Text :
- https://doi.org/10.1161/HYPERTENSIONAHA.114.04488